
NASDAQHealthcareBiotechnology
Latest quote
$20.73
−$0.31 · -1.47%
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Previous close
$20.73
−$0.31 · -1.47%
Regular session · ET · Market data may be delayed.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Day range
Current $20.73
52-week range
Current $20.73
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
39
Expensive
Sentiment
61
Bullish
Risk
44
Elevated Risk
Momentum
63
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Day range
Current $20.73
52-week range
Current $20.73
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$62.33
200.68% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 21, 2024 | 1:12 | — | — |
Effective Jun 21, 2024
1:12
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM6.02M0.01%71.54B USD0.19%$256.61-2.88%
Vanguard Morningstar Total Stock Market ETFVTI5.68M0.00%689.3B USD0.03%$340.02-3.52%
Vanguard Extended Market ETFVXF2.68M0.00%30.2B USD0.05%$211.44-3.21%
iShares Russell 2000 Value ETFIWN1.72M0.01%13.05B USD0.24%$198.84-2.08%
iShares Biotechnology ETFIBB1.51M0.01%10.53B USD0.44%$199.54-2.05%
Vanguard Russell 2000 ETFVTWO1.27M0.01%16.8B USD0.06%$103.76-2.76%
Vanguard U.S. Momentum Factor ETFVFMO895.03K0.05%1.9B USD0.13%$193.88-3.13%
iShares Micro-Cap ETFIWC681.64K0.06%1.09B USD0.60%$157.87-3.19%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
iShares Biotechnology ETFIBB
Vanguard Russell 2000 ETFVTWO
Vanguard U.S. Momentum Factor ETFVFMO
iShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.